Donepezil effects on language in children with Down syndrome: Results of the first 22‐week pilot clinical trial
- 21 July 2004
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 130A (3) , 325-326
- https://doi.org/10.1002/ajmg.a.30184
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate.2004
- Donepezil for the treatment of language deficits in adults with Down syndrome: A preliminary 24‐week open trialAmerican Journal of Medical Genetics Part A, 2002
- Cholinergic therapy for Down's syndromeThe Lancet, 1999